Collaborative Activities with BRAIN AG
BRAIN'S “BioActives & Performance Proteins" technology unit focuses on the identification and development of novel bioactive compounds for the food, feed and cosmetic industries. BRAIN employs state-of-the-art technologies to evaluate novel molecular targets and to engineer proprietary 2D as well as 3D cell-based model systems enabling high-troughput screenings using various physiological readouts.
BRAIN AG is a pioneer of industrial biotechnology. The company creates innovative solutions by combining a broad and in-depth biotechnology portfolio with a comprehensive proprietary resource of natural solutions: The “BioArchive“ encompasses high-performance microorganisms, natural compounds, fractions obtained from edible plant material, metagenome and enzyme libraries, as well as complete metabolic paths including previously uncultivable organisms.
With its wide range of biobased ingredients and processes, BRAIN makes a significant contribution to making consumer goods more effective and healthier (cosmetics, nutrition), and to making industrial processes more efficient and sustainable (e.g. CO2-use, precious metal recycling). BRAIN can look back on more than 100 successful joint R&D projects with major international companies.